Results 11 to 20 of about 37,023 (237)

Cannabinoids as treatment for nausea and vomiting [PDF]

open access: yesFrontiers in Pharmacology, 2016
Despite the advent of classic anti-emetics, chemotherapy-induced nausea is still problematic, with vomiting being somewhat better managed in the clinic. If post-treatment nausea and vomiting are not properly controlled, anticipatory nausea—a conditioned ...
Erin M. Rock, Linda A Parker
doaj   +2 more sources

Olanzapine for Chemotherapy-Induced Nausea and Vomiting [PDF]

open access: yesNew England Journal of Medicine, 2016
Excerpt: Navari and colleagues (July 14 issue)1 report on the use of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Rudolph M, Navari, Charles L, Loprinzi
openaire   +6 more sources

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

open access: yesTherapeutics and Clinical Risk Management, 2008
Mark A Ware1, Paul Daeninck2, Vincent Maida31Pain Center, McGill University Health Center, Montréal, Quebec, Canada; 2Pain and Symptom Clinic, CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3University of Toronto, Toronto, Ontario ...
Mark A Ware   +2 more
doaj   +1 more source

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant

open access: yesMiddle East Journal of Cancer, 2011
Antiemetics are given to cancer patients prior to their chemotherapy sessions to protect them from nausea and vomiting induced by chemotherapy. The responsible health care team member will choose the type of antiemetic required to prevent the patient ...
Muath Mohammed Abu Hilal
doaj   +1 more source

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

open access: yesCancer Management and Research, 2009
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, Monika Ducceschi, Luigi CelioMedical Oncology Unit 2, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, ItalyAbstract: Prevention of nausea and vomiting is the main goal of ...
Emilio Bajetta   +3 more
doaj   +1 more source

Efficacy and safety of acupuncture for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trial [PDF]

open access: yesFrontiers in Neurology
ObjectiveChemotherapy-induced nausea and vomiting (CINV) represents a common and debilitating side effects in cancer patients, often compromising treatment adherence and quality of life.
Jiongli Chen   +9 more
doaj   +2 more sources

Incidence and Risk Factors of Chemotherapy-Induced Nausea and Vomiting Among Adult Cancer Patients at Mbarara Regional Referral Hospital: A Prospective Study [PDF]

open access: yesClinical Pharmacology: Advances and Applications
Patrick Kitheka Muasya,1,2 Tadele Mekuriya Yadesa,1,3 John Isiiko,1,4 Julius Kyomya,1 Joel Oenga,1,2 Abubakar Amina,1,2 Godwin Nimusiima,1 Sebisaalu Joel,1 John Martin Tumwebaza,1,5 Kabera Radiana Makuza1 1Department of Pharmacy, Faculty of Medicine ...
Muasya PK   +9 more
doaj   +2 more sources

Economic evaluation of ondansetron: Preliminary analysis using clinical trial data prior to price setting [PDF]

open access: yes, 1992
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright © 1992 Macmillan Press Ltd.This study combines secondary analysis of efficacy and side-effect data from a randomised ...
Buxton, MJ, O'Brien, BJ
core   +6 more sources

Ice massage on chemotherapy induced nausea and vomiting

open access: yesمجله دانشگاه علوم پزشکی بیرجند, 2012
Background and Aim: Nausea and vomiting are the most common side effects of chemotherapy. The aim of the current study was to assess the effect of ice massage applied to the pericardium 6 (P6 or Neigaun) acupuncture point on nausea– vomiting due to
Mehdi Sadeghi Shermeh   +3 more
doaj   +1 more source

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy